medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2022-8-23-28medalphabet-2597Research ArticleОБЗОР ЛИТЕРАТУРЫОбзор наиболее распространенных заболеваний вульвовагинальной областиOverview of most common diseases of vulvovaginal regionhttps://orcid.org/0000-0003-0521-0333СуркичинС. И.SurkichinS. I.

 Суркичин Сергей Иванович, к.м.н., доцент кафедры дерматовенерологии и косметологии

 Surkichin Sergey I., PhD Med, associate professor at Dept of Dermatovenerology and Cosmetology 

surkichinsi24@mail.ruhttps://orcid.org/0000-0003-1911-6743МайоровР. Ю.MayorovR. Yu.

 Майоров Роман Юрьевич, врач-дерматовенеролог, аспирант кафедры дерматовенерологии и косметологии

 Mayorov Roman Yu., dermatovenereologist, postgraduate student of Dept of Dermatovenereology and Cosmetology 

ФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента Российской ФедерацииРоссияCentral State Medical AcademyRussian Federation20221705202208Дерматология (1)2328Copyright © Суркичин С.И., Майоров Р.Ю., 20222022Суркичин С.И., Майоров Р.Ю.Surkichin S.I., Mayorov R.Y.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/2597

Дерматозы вульвы – это воспалительные состояния, проявляющиеся множеством симптомов, доставляющих женщине сильный дискомфорт и значительно снижающие качество жизни. Основными симптомами являются диспареуния, дизурия, зуд, сухость кожных покровов и слизистых в области вульвы. Клиническая картина может быть ограничена только вульвой либо связана с экстрагенитальной локализацией. Сложно переоценить важность дифференциальной диагностики дерматозов вульвы, так как большинство из них клинически являются очень похожими друг на друга. От постановки правильного диагноза зависит не только излечение от конкретного заболевания, но и предотвращение развития онкологии, ведь некоторые нозологии могут малигнизироваться. Например, красный плоский лишай и склероатрофический лихен могут превращаться в плоскоклеточную карциному. Наиболее распространенным методом терапии являются топические глюкокортикостероиды, но в последние несколько лет появились более эффективные и сложные, в т.ч. комбинированные методики терапии дерматозов вульвы, такие как CO 2-лазер, Er: Yag, Prp, биоревитализация и др.

Vulvar dermatosis is an inflammatory condition that manifests itself in a variety of symptoms that cause severe discomfort to a woman and signifcantly reduce the quality of life. The main symptoms are dyspareunia, dysuria, itching, dry skin and mucous membranes in the vulva. The clinical picture may be limited only to the vulva, or associated with extragenital localization. It is diffcult to overestimate the importance of the differential diagnosis of vulvar dermatoses, since most of them are clinically very similar to each other. Not only the cure for a specifc disease depends on the correct diagnosis, but also the prevention of the development of oncology, because some nosologies can become malignant. For example, lichen planus and lichen sclerosus can develop into squamous cell carcinoma. The most common method of therapy is topical glucocorticosteroids, but in the last few years more effective and complex ones have appeared, incl. combined methods for the treatment of dermatoses of the vulva, such as CO 2 laser, Er: Yag, Prp, biorevitalization, etc.

склероатрофический лихенкрасный плоский лишайпсориазкандидозCO2-лазерPrpдиспареуниядизуриязудlichen sclerosuslichen planuspsoriasiscandidiasisCO2 laserPrpdyspareuniadysuriapruritusReferencesCooper S.M., Ali I., Baldo M., et al. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008; 144: 1432e5.Cooper S.M., Ali I., Baldo M., et al. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008; 144: 1432e5.Meyrick Thomas R.H., Ridley C.M., McGibbon D.H., et al. Lichen sclerosus et atrophicus and autoimmunityea study of 350 women. Br J Dermatol 1988; 118: 41e6Meyrick Thomas R.H., Ridley C.M., McGibbon D.H., et al. Lichen sclerosus et atrophicus and autoimmunityea study of 350 women. Br J Dermatol 1988; 118: 41e6Birenbaum D.L., Young R.C. High prevalence of thyroid disease in patients with lichen sclerosus. J Reprod Med 2007; 52: 28e33.Birenbaum D.L., Young R.C. High prevalence of thyroid disease in patients with lichen sclerosus. J Reprod Med 2007; 52: 28e33.Sherman V., McPherson T., Baldo M., et al. The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. J Eur Acad Dermatol Venereol 2010; 24: 1031e4.Sherman V., McPherson T., Baldo M., et al. The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. J Eur Acad Dermatol Venereol 2010; 24: 1031e4.Gao X.H., Barnardo M.C., Winsey S., et al. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/DQB10201/02/03 haplotype protects from vulval lichen sclerosus. J Invest Dermatol 2005; 125: 895e9.Gao X.H., Barnardo M.C., Winsey S., et al. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/DQB10201/02/03 haplotype protects from vulval lichen sclerosus. J Invest Dermatol 2005; 125: 895e9.Moyal-Barracco M., & Wendling J. (2014). Vulvar dermatosis. Best Practice & Research Clinical Obstetrics & Gynaecology, 28 (7), 946–958. DOI: 10.1016/j.bpobgyn.2014.07.005.Moyal-Barracco M., & Wendling J. (2014). Vulvar dermatosis. Best Practice & Research Clinical Obstetrics & Gynaecology, 28 (7), 946–958. DOI: 10.1016/j.bpobgyn.2014.07.005.Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus. Kirtschig G., Becker K., Günthert A., Jasaitiene D., Cooper S, Chi C. C., Kreuter A., Rall K. K., Aberer W., Riechardt S., Casabona F., Powell J., Brackenbury F., Erdmann R., Lazzeri M., Barbagli G., Wojnarowska F.J. Eur Acad Dermatol Venereol. 2015 Oct; 29 (10): e1–43.Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus. Kirtschig G., Becker K., Günthert A., Jasaitiene D., Cooper S, Chi C. C., Kreuter A., Rall K. K., Aberer W., Riechardt S., Casabona F., Powell J., Brackenbury F., Erdmann R., Lazzeri M., Barbagli G., Wojnarowska F.J. Eur Acad Dermatol Venereol. 2015 Oct; 29 (10): e1–43.Gibbon K. Kirtschig G., Cooper S., editors. Atopic eczema, lichen simplex and seborrheic dermatitis. Gynecologic dermatology – symptoms, signs and clinical management. 2016: 65–69.Gibbon K. Kirtschig G., Cooper S., editors. Atopic eczema, lichen simplex and seborrheic dermatitis. Gynecologic dermatology – symptoms, signs and clinical management. 2016: 65–69.Selim M.A., Hoang M.P. A histologic review of vulvar inflammatory dermatosis and intraepithelial neoplasm. Dermatol Clin 2010; 28: 649e67.Selim M.A., Hoang M.P. A histologic review of vulvar inflammatory dermatosis and intraepithelial neoplasm. Dermatol Clin 2010; 28: 649e67.Федотова К.Ю., Жукова О.В., Круглова Л.С., Пташинский Р.И. Красный плоский лишай: этиология, патогенез, клинические формы, гистологическая картина и основные принципы лечения. Клиническая дерматология и венерология. 2014; 12 (6): 9–20.Fedotova K. Yu., Zhukova O.V., Kruglova L.S., Ptashinsky R.I. Lichen planus: etiology, pathogenesis, clinical forms, histological picture and basic principles of treatment. Clinical dermatology and venereology. 2014; 12 (6): 9–20.Chew A., Stefanato C., Savarese I., et al. Clinical patterns of lichen planopilaris in patients with vulval lichen planus. Br J Dermatol 2014; 170: 218–20.Chew A., Stefanato C., Savarese I., et al. Clinical patterns of lichen planopilaris in patients with vulval lichen planus. Br J Dermatol 2014; 170: 218–20.Goldstein A., Metz A. Vulvar lichen planus. Clin Obstet Gynecol 2005; 48: 818–23.Goldstein A., Metz A. Vulvar lichen planus. Clin Obstet Gynecol 2005; 48: 818–23.Woelber L., Prieske K., Mendling W., Schmalfeldt B., Tietz H.J., Jaeger A. Vulvar pruritus –Causes, Diagnosis and Therapeutic Approach. Dtsch Arztebl Int. 2020; 116 (8): 126–133. DOI: 10.3238/arztebl.2020.0126.Woelber L., Prieske K., Mendling W., Schmalfeldt B., Tietz H.J., Jaeger A. Vulvar pruritus –Causes, Diagnosis and Therapeutic Approach. Dtsch Arztebl Int. 2020; 116 (8): 126–133. DOI: 10.3238/arztebl.2020.0126.Day T., Weigner J., Scurry J. Classic and Hypertrophic Vulvar Lichen Planus. J Low Genit Tract Dis. 2018; 22 (4): 387–395. DOI: 10.1097/LGT.0000000000000419.Day T., Weigner J., Scurry J. Classic and Hypertrophic Vulvar Lichen Planus. J Low Genit Tract Dis. 2018; 22 (4): 387–395. DOI: 10.1097/LGT.0000000000000419.Beck K.M., Yang E.J., Sanchez I.M., Liao W. Treatment of Genital Psoriasis: A Systematic Review. Dermatol Ther (Heidelb). 2018; 8 (4): 509–525. DOI: 10.1007/s13555–018–0257-y.Beck K.M., Yang E.J., Sanchez I.M., Liao W. Treatment of Genital Psoriasis: A Systematic Review. Dermatol Ther (Heidelb). 2018; 8 (4): 509–525. DOI: 10.1007/s13555–018–0257-y.Dalziel K.L., Millard P.R., Wojnarowska F. The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol Propionate 0.05%) cream. Br.J. Dermatol. 1991; 124: 461–464. DOI: 10.1111/j.1365–2133.1991.tb00626.x.Dalziel K.L., Millard P.R., Wojnarowska F. The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol Propionate 0.05%) cream. Br.J. Dermatol. 1991; 124: 461–464. DOI: 10.1111/j.1365–2133.1991.tb00626.x.Shi L., Miao F., Zhang L., Zhang G., Wang P., Ji J., Huang Z., Wang H., Wang X. Comparison of 5-Aminolevulinic Acid Photodynamic Therapy and Clobetasol Propionate in Treatment of Vulvar Lichen Sclerosus. Acta Derm. Venereol. 2016; 96: 684–688. DOI: 10.2340/00015555–2341.Shi L., Miao F., Zhang L., Zhang G., Wang P., Ji J., Huang Z., Wang H., Wang X. Comparison of 5-Aminolevulinic Acid Photodynamic Therapy and Clobetasol Propionate in Treatment of Vulvar Lichen Sclerosus. Acta Derm. Venereol. 2016; 96: 684–688. DOI: 10.2340/00015555–2341.Virgili A., Borghi A., Toni G., Minghetti S., Corazza M. First randomized trial on clobetasol propionate and mometasone furoate in the treatment of vulvar lichen sclerosus: Results of effcacy and tolerability. Br.J. Dermatol. 2014; 171: 388–396. DOI: 10.1111/bjd.12910.Virgili A., Borghi A., Toni G., Minghetti S., Corazza M. First randomized trial on clobetasol propionate and mometasone furoate in the treatment of vulvar lichen sclerosus: Results of effcacy and tolerability. Br.J. Dermatol. 2014; 171: 388–396. DOI: 10.1111/bjd.12910.Cattaneo A., De Magnis A., Botti E., Sonni L., Carli P., Taddei G.L. Topical mometasone furoate for vulvar lichen sclerosus. J. Reprod. Med. 2003; 48: 444–448.Cattaneo A., De Magnis A., Botti E., Sonni L., Carli P., Taddei G.L. Topical mometasone furoate for vulvar lichen sclerosus. J. Reprod. Med. 2003; 48: 444–448.Goldstein A.T., Marinoff S.C., Christopher K. Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girl. J. Pediatr. Adolesc. Gynecol. 2004; 17: 35–37. DOI: 10.1016/j.jpag.2003.11.013.Goldstein A.T., Marinoff S.C., Christopher K. Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girl. J. Pediatr. Adolesc. Gynecol. 2004; 17: 35–37. DOI: 10.1016/j.jpag.2003.11.013.Goldstein A.T., Creasey A., Pfau R., Phillips D., Burrows L.J. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. J. Am. Acad. Dermatol. 2011; 64: e99–e104. DOI: 10.1016/j.jaad.2010.06.011.Goldstein A.T., Creasey A., Pfau R., Phillips D., Burrows L.J. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. J. Am. Acad. Dermatol. 2011; 64: e99–e104. DOI: 10.1016/j.jaad.2010.06.011.Funaro D., Lovett A., Leroux N., Powell J. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus. J. Am. Acad. Dermatol. 2014; 71: 84–91. DOI: 10.1016/j.jaad.2014.02.019.Funaro D., Lovett A., Leroux N., Powell J. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus. J. Am. Acad. Dermatol. 2014; 71: 84–91. DOI: 10.1016/j.jaad.2014.02.019.Başkan E.B., Turan H., Tunali S., Toker S.C., Saricaoglu H. Open-label trial of cyclosporine for vulvar lichen sclerosus. J. Am. Acad. Dermatol. 2007; 57: 276–278. DOI: 10.1016/j.jaad.2007.03.006.Başkan E.B., Turan H., Tunali S., Toker S.C., Saricaoglu H. Open-label trial of cyclosporine for vulvar lichen sclerosus. J. Am. Acad. Dermatol. 2007; 57: 276–278. DOI: 10.1016/j.jaad.2007.03.006.Fritsch P.O. Retinoids in psoriasis and disorders of keratinization. J. Am. Acad. Dermatol. 1992; 27: S8–S14. DOI: 10.1016/S0190–9622 (08)80253–8.Fritsch P.O. Retinoids in psoriasis and disorders of keratinization. J. Am. Acad. Dermatol. 1992; 27: S8–S14. DOI: 10.1016/S0190–9622 (08)80253–8.Griffths C., Russman A.N., Majmudar G., Singer R.S., Hamilton T.A., Voorhees J.J. Restoration of Collagen Formation in Photodamaged Human Skin by Tretinoin (Retinoic Acid). N. Engl. J. Med. 1993; 329: 530–535. DOI: 10.1056/NEJM199308193290803.Griffths C., Russman A.N., Majmudar G., Singer R.S., Hamilton T.A., Voorhees J.J. Restoration of Collagen Formation in Photodamaged Human Skin by Tretinoin (Retinoic Acid). N. Engl. J. Med. 1993; 329: 530–535. DOI: 10.1056/NEJM199308193290803.Bikowski J. B. Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids. J. Drugs DERMATOL. JDD. 2005; 4: 41–47.Bikowski J. B. Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids. J. Drugs DERMATOL. JDD. 2005; 4: 41–47.Sadownik L.A., Koert E., Maher C., Smith K.B. A Qualitative Exploration of Women’s Experiences of Living with Chronic Vulvar Dermatoses. J. Sex. Med. 2020; 17: 1740–1750. DOI: 10.1016/j.jsxm.2020.06.016.Sadownik L.A., Koert E., Maher C., Smith K.B. A Qualitative Exploration of Women’s Experiences of Living with Chronic Vulvar Dermatoses. J. Sex. Med. 2020; 17: 1740–1750. DOI: 10.1016/j.jsxm.2020.06.016.DiGiovanna J.J. Retinoid chemoprevention in the high-risk patient. J. Am. Acad. Dermatol. 1998; 39: S82–S85. DOI: 10.1016/S0190–9622 (98)70451–7.DiGiovanna J.J. Retinoid chemoprevention in the high-risk patient. J. Am. Acad. Dermatol. 1998; 39: S82–S85. DOI: 10.1016/S0190–9622 (98)70451–7.Virgili A., Corazza M., Bianchi A., Mollica G., Califano A. Open study of topical 0.025% tretinoin in the treatment of vulvar lichen sclerosus. One year of therapy. J. Reprod. Med. 1995; 40: 614–618.Virgili A., Corazza M., Bianchi A., Mollica G., Califano A. Open study of topical 0.025% tretinoin in the treatment of vulvar lichen sclerosus. One year of therapy. J. Reprod. Med. 1995; 40: 614–618.Prodromidou A., Chatziioannou E., Daskalakis G., Stergios K., Pergialiotis V. Photodynamic Therapy for Vulvar Lichen Sclerosus – A Systematic Review. J. Low. Genit. Tract Dis. 2018; 22: 58–65. DOI: 10.1097/LGT.0000000000000362.Prodromidou A., Chatziioannou E., Daskalakis G., Stergios K., Pergialiotis V. Photodynamic Therapy for Vulvar Lichen Sclerosus – A Systematic Review. J. Low. Genit. Tract Dis. 2018; 22: 58–65. DOI: 10.1097/LGT.0000000000000362.Preti M., Vieira-Baptista P., Digesu G.A., Bretschneider C.E., Damaser M., Demirkesen O., Heller D.S., Mangir N., Marchitelli C., Mourad S., et al. The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document. Neurourol. Urodyn. 2019; 38: 1009–1023. DOI: 10.1002/nau.23931.Preti M., Vieira-Baptista P., Digesu G.A., Bretschneider C.E., Damaser M., Demirkesen O., Heller D.S., Mangir N., Marchitelli C., Mourad S., et al. The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document. Neurourol. Urodyn. 2019; 38: 1009–1023. DOI: 10.1002/nau.23931.Peterson C. M., Lane J. E., Ratz J. L. Successful Carbon Dioxide Laser Therapy for Refractory Anogenital Lichen Sclerosus. Dermatol. Surg. 2004; 30: 1148–1151. DOI: 10.1111/j.1524–4725.2004.30343.x.Peterson C. M., Lane J. E., Ratz J. L. Successful Carbon Dioxide Laser Therapy for Refractory Anogenital Lichen Sclerosus. Dermatol. Surg. 2004; 30: 1148–1151. DOI: 10.1111/j.1524–4725.2004.30343.x.Lee A., Lim A., Fischer G. Fractional carbon dioxide laser in recalcitrant vulval lichen sclerosus. Australas. J. Dermatol. 2015; 57: 39–43. DOI: 10.1111/ajd.12305.Lee A., Lim A., Fischer G. Fractional carbon dioxide laser in recalcitrant vulval lichen sclerosus. Australas. J. Dermatol. 2015; 57: 39–43. DOI: 10.1111/ajd.12305.Balchander D., Nyirjesy P. Fractionated CO2 Laser as Therapy in Recalcitrant Lichen Sclerosus. J. Low. Genit. Tract Dis. 2020; 24: 225–228. DOI: 10.1097/LGT.0000000000000512.Balchander D., Nyirjesy P. Fractionated CO2 Laser as Therapy in Recalcitrant Lichen Sclerosus. J. Low. Genit. Tract Dis. 2020; 24: 225–228. DOI: 10.1097/LGT.0000000000000512.Kamilos M. F., Aguiar L. M., Batista V. H., Roa C. L., Aguiar F. N., Soares J. M., Baracat E.C. Microablative fractional radiofrequency as a therapeutic option for vulvar lichen sclerosus: A pilot study. Clinics. 2021; 76: e2567. DOI: 10.6061/clinics/2021/e2567.Kamilos M. F., Aguiar L. M., Batista V. H., Roa C. L., Aguiar F. N., Soares J. M., Baracat E.C. Microablative fractional radiofrequency as a therapeutic option for vulvar lichen sclerosus: A pilot study. Clinics. 2021; 76: e2567. DOI: 10.6061/clinics/2021/e2567.Li H.O.-Y., Bailey A.M.J., Tan M.G., Dover J.S. Lasers as an adjuvant for vulvar lichen sclerosus: A systematic review and meta-analysis. J. Am. Acad. Dermatol. 2021 DOI:10.1016/j.jaad.2021.02.081.Li H.O.-Y., Bailey A.M.J., Tan M.G., Dover J.S. Lasers as an adjuvant for vulvar lichen sclerosus: A systematic review and meta-analysis. J. Am. Acad. Dermatol. 2021 DOI:10.1016/j.jaad.2021.02.081.Griffn M.M.F., Almadori M.A., Butler P. Use of Lipotransfer in Scleroderma. Aesthetic Surg. J. 2017; 37: S33–S37. DOI: 10.1093/asj/sjx067.Griffn M.M.F., Almadori M.A., Butler P. Use of Lipotransfer in Scleroderma. Aesthetic Surg. J. 2017; 37: S33–S37. DOI: 10.1093/asj/sjx067.Abu-Ghname A., Perdanasari A.T., Reece E.M. Principles and Applications of Fat Grafting in Plastic Surgery. Semin. Plast. Surg. 2019; 33: 147–154. DOI: 10.1055/s-0039–1693438.Abu-Ghname A., Perdanasari A.T., Reece E.M. Principles and Applications of Fat Grafting in Plastic Surgery. Semin. Plast. Surg. 2019; 33: 147–154. DOI: 10.1055/s-0039–1693438.Goldstein A. T., Mitchell L., Govind V., Heller D. A randomized double-blind placebo-controlled trial of autologous platelet-rich plasma intradermal injections for the treatment of vulvar lichen sclerosus. J. Am. Acad. Dermatol. 2019; 80: 1788–1789. DOI: 10.1016/j.jaad.2018.12.060.Goldstein A. T., Mitchell L., Govind V., Heller D. A randomized double-blind placebo-controlled trial of autologous platelet-rich plasma intradermal injections for the treatment of vulvar lichen sclerosus. J. Am. Acad. Dermatol. 2019; 80: 1788–1789. DOI: 10.1016/j.jaad.2018.12.060.Tedesco M., Bellei B., Garelli V., Caputo S., Latini A., Giuliani M., Cota C., Chichierchia G., Romani C., Foddai M.L., et al. Adipose tissue stromal vascular fraction and adipose tissue stromal vascular fraction plus platelet-rich plasma grafting: New regenerative perspectives in genital lichen sclerosus. Dermatol. Ther. 2020; 33. DOI: 10.1111/dth.14277.Tedesco M., Bellei B., Garelli V., Caputo S., Latini A., Giuliani M., Cota C., Chichierchia G., Romani C., Foddai M.L., et al. Adipose tissue stromal vascular fraction and adipose tissue stromal vascular fraction plus platelet-rich plasma grafting: New regenerative perspectives in genital lichen sclerosus. Dermatol. Ther. 2020; 33. DOI: 10.1111/dth.14277.Helgesen A.L., Warloe T., Pripp A.H., Kirschner R., Peng Q., Tanbo T., et al. Vulvovaginal photodynamic therapy vs. topical corticosteroids in genital erosive lichen planus: a randomized controlled trial. Br J Dermatol. 2015; 173: 1156–62.Helgesen A.L., Warloe T., Pripp A.H., Kirschner R., Peng Q., Tanbo T., et al. Vulvovaginal photodynamic therapy vs. topical corticosteroids in genital erosive lichen planus: a randomized controlled trial. Br J Dermatol. 2015; 173: 1156–62.Neill S.M., Lewis F.M., Tatnall F.M., Cox N.H. British Association of Dermatologists. British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010. Br J Dermatol. 2010; 163: 672–82.Neill S.M., Lewis F.M., Tatnall F.M., Cox N.H. British Association of Dermatologists. British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010. Br J Dermatol. 2010; 163: 672–82.Byrd J. A., Davis M. D., Rogers R. S. Recalcitrant symptomatic vulvar lichen planus: Response to topical tacrolimus. Arch Dermatol. 2004; 140: 715–20.Byrd J. A., Davis M. D., Rogers R. S. Recalcitrant symptomatic vulvar lichen planus: Response to topical tacrolimus. Arch Dermatol. 2004; 140: 715–20.DE Paola M., DE Piano E., Pisani C. Genital hypertrophicus lichen planus successfully treated with topical pimecrolimus. G Ital Dermatol Venereol. 2018; 153: 296–98.DE Paola M., DE Piano E., Pisani C. Genital hypertrophicus lichen planus successfully treated with topical pimecrolimus. G Ital Dermatol Venereol. 2018; 153: 296–98.Fahy C.M.R., Torgerson R.R., Davis M.D. Lichen planus affecting the female genitalia: A retrospective review of patients at Mayo Clinic. J Am Acad Dermatol. 2017; 77: 1053–1059.Fahy C.M.R., Torgerson R.R., Davis M.D. Lichen planus affecting the female genitalia: A retrospective review of patients at Mayo Clinic. J Am Acad Dermatol. 2017; 77: 1053–1059.Jang N., Fischer G. Treatment of erosive vulvovaginal lichen planus with methotrexate. Australas J Dermatol. 2008; 49: 216–9.Jang N., Fischer G. Treatment of erosive vulvovaginal lichen planus with methotrexate. Australas J Dermatol. 2008; 49: 216–9.Kortekangas-Savolainen O., Kiilholma P. Treatment of vulvovaginal erosive and stenosing lichen planus by surgical dilatation andmethotrexate. Acta Obstet Gynecol Scand. 2007; 86: 339–43.Kortekangas-Savolainen O., Kiilholma P. Treatment of vulvovaginal erosive and stenosing lichen planus by surgical dilatation andmethotrexate. Acta Obstet Gynecol Scand. 2007; 86: 339–43.Ho J., Hantash B. Systematic review of current systemic treatment options for erosive lichen planus. Expert Rev Dermatol. 2012; 7: 269–82.Ho J., Hantash B. Systematic review of current systemic treatment options for erosive lichen planus. Expert Rev Dermatol. 2012; 7: 269–82.Poon F., De Cruz R., Hall A. Acitretin in erosive penile lichen planus. Australas J Dermatol. 2017; 58: e87–e90.Poon F., De Cruz R., Hall A. Acitretin in erosive penile lichen planus. Australas J Dermatol. 2017; 58: e87–e90.Petropoulou H., Kontochristopoulos G., Kalogirou O., Panteri I., Zakopoulou N. Effective treatment of erosive lichen planus with thalidomide and topical tacrolimus. Int J Dermatol. 2006; 45: 1244–5.Petropoulou H., Kontochristopoulos G., Kalogirou O., Panteri I., Zakopoulou N. Effective treatment of erosive lichen planus with thalidomide and topical tacrolimus. Int J Dermatol. 2006; 45: 1244–5.Fahy C.M.R., Torgerson R.R., Davis M.D. Lichen planus affecting the female genitalia: A retrospective review of patients at Mayo Clinic. J Am Acad Dermatol. 2017; 77: 1053–1059.Fahy C.M.R., Torgerson R.R., Davis M.D. Lichen planus affecting the female genitalia: A retrospective review of patients at Mayo Clinic. J Am Acad Dermatol. 2017; 77: 1053–1059.Menter A., Korman N.J., Elmets C.A., Feldman S.R., Gelfand J.M., Gordon K.B., Gottlieb A.B., Koo J.Y., Lebwohl M., Lim H.W., van Voorhees A.S., Beutner K.R., Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009; 61: 451–485. DOI: 10.1016/j.jaad.2009.03.027.Menter A., Korman N.J., Elmets C.A., Feldman S.R., Gelfand J.M., Gordon K.B., Gottlieb A.B., Koo J.Y., Lebwohl M., Lim H.W., van Voorhees A.S., Beutner K.R., Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009; 61: 451–485. DOI: 10.1016/j.jaad.2009.03.027.Kivelevitch D., Frieder J., Watson I, Paek S. Y., Menter M. A. Pharmacotherapeutic approaches for treating psoriasis in diffcult-to-treat areas. Expert Opin Pharmacother. 2018; 19: 561–575. DOI: 10.1080/14656566.2018.1448788.Kivelevitch D., Frieder J., Watson I, Paek S. Y., Menter M. A. Pharmacotherapeutic approaches for treating psoriasis in diffcult-to-treat areas. Expert Opin Pharmacother. 2018; 19: 561–575. DOI: 10.1080/14656566.2018.1448788.Czuczwar P., Stepniak A., Goren A., Wrona W., Paszkowski T., Pawlaczyk M., Piekarska-Myslinska D., Wozniak S., Pietrzak A. Genital psoriasis: a hidden multidisciplinary problem – a review of literature. Ginekol Pol. 2016; 87: 717–721. DOI: 10.5603/GP.2016.0074.Czuczwar P., Stepniak A., Goren A., Wrona W., Paszkowski T., Pawlaczyk M., Piekarska-Myslinska D., Wozniak S., Pietrzak A. Genital psoriasis: a hidden multidisciplinary problem – a review of literature. Ginekol Pol. 2016; 87: 717–721. DOI: 10.5603/GP.2016.0074.Bissonnette R., Nigen S., Bolduc C. Effcacy and tolerability of topical tacrolimus ointment for the treatment of male genital psoriasis. J Cutan Med Surg. 2008; 12: 230–234. DOI: 10.2310/7750.2008.07055.Bissonnette R., Nigen S., Bolduc C. Effcacy and tolerability of topical tacrolimus ointment for the treatment of male genital psoriasis. J Cutan Med Surg. 2008; 12: 230–234. DOI: 10.2310/7750.2008.07055.Menter A., Korman N.J., Elmets C.A., Feldman S.R., Gelfand J.M., Gordon K.B., Gottlieb A.B., Koo J.Y., Lebwohl M., Lim H.W., van Voorhees A.S., Beutner K.R., Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009; 61: 451–485. DOI: 10.1016/j.jaad.2009.03.027.Menter A., Korman N.J., Elmets C.A., Feldman S.R., Gelfand J.M., Gordon K.B., Gottlieb A.B., Koo J.Y., Lebwohl M., Lim H.W., van Voorhees A.S., Beutner K.R., Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009; 61: 451–485. DOI: 10.1016/j.jaad.2009.03.027.Ryan C., Menter A., Guenther L, Blauvelt A., Bissonnette R., Yang F., Potts Bleakman A. Effcacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled, phase 3b clinical trial in patients with moderate-to-severe genital psoriasis. J Sexual Med. 2018; 15: S6–S7. DOI: 10.1016/j.jsxm.2017.11.031.Ryan C., Menter A., Guenther L, Blauvelt A., Bissonnette R., Yang F., Potts Bleakman A. Effcacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled, phase 3b clinical trial in patients with moderate-to-severe genital psoriasis. J Sexual Med. 2018; 15: S6–S7. DOI: 10.1016/j.jsxm.2017.11.031.Job A.M., Kaimal S. Lichen planus hypertrophicus of the vulva – a rare entity. Int J STD AIDS. 2017; 28: 1048–50.Job A.M., Kaimal S. Lichen planus hypertrophicus of the vulva – a rare entity. Int J STD AIDS. 2017; 28: 1048–50.Венерические болезни и дерматозы аногенитальной области: иллюстрированное руководство для врачей. Д.В. Заславский, А.А. Сыдиков, А.М. Иванов, Р.А. Насыров. М.: ГЭОТАР-Медиа, 2020. 640 с. ISBN978–5–9704–5380–3.Venereal diseases and dermatoses of the anogenital region: an illustrated guide for physicians. D.V. Zaslavsky, A.A. Sydikov, A.M. Ivanov, R.A. Nasyrov. M.: GEOTAR-Media, 2020. 640 p. ISBN978–5–9704–5380–3.

The authors declare that there are no conflicts of interest present.